MedTrace Logo

Role of Medical Treatment in Endometriosis Patients Undergoing ICSI

NCT06577974 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2024-08-29

No results posted yet for this study

Summary

The aim of this study to assess the effect of medical treatment prior to stimulation on fertility (ICSI) outcome in cases with endometriosis associated infertility.

Conditions

  • Endometriosis

Interventions

DRUG

Combined contraceptive pills (Yasmin)

medical pretreatment prior to ICSI

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Taha, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-02-28
Completion
2025-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577974 on ClinicalTrials.gov